Heart Health


January 24, 2018

CR Expo China 2017 Poised to Boost Rise of Assistive Device Industry

August 21, 2017

The press conference for Care & Rehabilitation Expo China 2017 was held at China Disabled Persons’ Federation, on August 14th, 2017. Present at the conference are leaders including HU Xiangyang, Director of Rehabilitation Department of China Disabled Persons’ Federation, LI Xi, Director of China Assistive Devices and Technology Centre for Persons with Disabilities, OU Ling, […]

Sales hopes for new Novartis, Merck heart drugs under microscope

June 29, 2017

Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as to whether this scientific success will translate into blockbuster sales. Detailed data on both Novartis’s canakinumab and Merck’s anacetrapib will be presented on Aug. 27 and 29 at the annual […]

Alphabet has Quietly Become the Most Influential Player in Silicon Valley Health Tech

April 20, 2017

Former Google executive Stephanie Tilenius recalls pitching an idea to Google X chief Astro Teller for a health-tracking smartwatch in 2012, but there wasn’t much enthusiasm for the idea. At the time, she said, the major health projects on the research team included a prototype for a contact lens to measure blood sugar and a […]

Bellerophon Therapeutics and Worldwide Clinical Trials Selected as Finalists in 2017 Care Awards

March 16, 2017

MORRISVILLE, NC, March 7, 2017 – Worldwide Clinical Trials (www.worldwide.com) and Bellerophon Therapeutics (www.bellerophon.com) have been selected as finalists in the 2017 Clinical Research & Excellence (CARE) Awards in the “Clinical Partnership of the Year” category. This category recognizes collaborations between organizations whose clinical trial activity has set a new benchmark in partnering activity. Partners […]

Early results show irregular heartbeat improves after stem cells treatment

March 6, 2017

Durham, NC – A new study published this month in STEM CELLS Translational Medicine indicates that treating heart patients with mesenchymal stem cells (MSCs) does not increase their risk of irregular heart beat (arrhythmia). In fact, the MSCs had the opposite effect and showed promise of improving the condition. “This could be an important breakthrough […]